Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Loss of miR-210 leads to progressive retinal degeneration in Drosophila melanogaster.

Weigelt CM, Hahn O, Arlt K, Gruhn M, Jahn AJ, Eßer J, Werner JA, Klein C, Büschges A, Grönke S, Partridge L.

Life Sci Alliance. 2019 Jan 22;2(1). pii: e201800149. doi: 10.26508/lsa.201800149. Print 2019 Feb.

2.

Development and Characterization of a Spontaneously Metastatic Patient-Derived Xenograft Model of Human Prostate Cancer.

Lange T, Oh-Hohenhorst SJ, Joosse SA, Pantel K, Hahn O, Gosau T, Dyshlovoy SA, Wellbrock J, Feldhaus S, Maar H, Gehrcke R, Kluth M, Simon R, Schlomm T, Huland H, Schumacher U.

Sci Rep. 2018 Dec 3;8(1):17535. doi: 10.1038/s41598-018-35695-8.

3.

Hepatic gene body hypermethylation is a shared epigenetic signature of murine longevity.

Hahn O, Stubbs TM, Reik W, Grönke S, Beyer A, Partridge L.

PLoS Genet. 2018 Nov 21;14(11):e1007766. doi: 10.1371/journal.pgen.1007766. eCollection 2018 Nov.

4.

Corrigendum to 'Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update' [Eur J Cancer 94 (May 2018) 115-125].

Choueiri TK, Hessel C, Halabi S, Sanford B, Michaelson MD, Hahn O, Walsh M, Olencki T, Picus J, Small EJ, Dakhil S, Feldman DR, Mangeshkar M, Scheffold C, George D, Morris MJ.

Eur J Cancer. 2018 Nov;103:287. doi: 10.1016/j.ejca.2018.09.022. Epub 2018 Sep 27. No abstract available.

5.

Expression of N471D strumpellin leads to defects in the endolysosomal system.

Song L, Rijal R, Karow M, Stumpf M, Hahn O, Park L, Insall R, Schröder R, Hofmann A, Clemen CS, Eichinger L.

Dis Model Mech. 2018 Sep 13;11(9). pii: dmm033449. doi: 10.1242/dmm.033449.

6.

PALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast cancer.

Lynce F, Saleh M, Shajahan-Haq A, Gallagher C, Dilawari A, Hahn O, Abu-Khalaf M, Cai L, Pohlmann P, Mohebtash M, Kamugisha L, Isaacs C.

Contemp Clin Trials Commun. 2018 May 7;10:190-192. doi: 10.1016/j.conctc.2018.05.012. eCollection 2018 Jun.

7.

Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study.

Li D, McCall LM, Hahn OM, Hudis CA, Cohen HJ, Muss HB, Jatoi A, Lafky JM, Ballman KV, Winer EP, Tripathy D, Schneider B, Barry W, Dickler MN, Hurria A.

Breast Cancer Res Treat. 2018 Sep;171(2):325-334. doi: 10.1007/s10549-018-4828-5. Epub 2018 May 22.

PMID:
29789969
8.

Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update.

Choueiri TK, Hessel C, Halabi S, Sanford B, Michaelson MD, Hahn O, Walsh M, Olencki T, Picus J, Small EJ, Dakhil S, Feldman DR, Mangeshkar M, Scheffold C, George D, Morris MJ.

Eur J Cancer. 2018 May;94:115-125. doi: 10.1016/j.ejca.2018.02.012. Epub 2018 Mar 20. Erratum in: Eur J Cancer. 2018 Nov;103:287.

9.

Phase 1 Study of Accelerated Hypofractionated Radiation Therapy With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer: CALGB 31102 (Alliance).

Urbanic JJ, Wang X, Bogart JA, Stinchcombe TE, Hodgson L, Schild SE, Bazhenova L, Hahn O, Salgia R, Vokes EE.

Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):177-185. doi: 10.1016/j.ijrobp.2018.01.046. Epub 2018 Jan 31.

PMID:
29487024
10.

Capabilities and limitations of handheld Diffuse Reflectance Infrared Fourier Transform Spectroscopy (DRIFTS) for the analysis of colourants and binders in 20th-century reverse paintings on glass.

Steger S, Stege H, Bretz S, Hahn O.

Spectrochim Acta A Mol Biomol Spectrosc. 2018 Apr 15;195:103-112. doi: 10.1016/j.saa.2018.01.057. Epub 2018 Feb 3.

PMID:
29414566
11.

Treatment for Localized T1a Clear Cell Renal Cell Carcinoma: Survival Benefit for Cryosurgery and Thermal Ablation Compared to Deferred Therapy.

Uhlig A, Hahn O, Strauss A, Lotz J, Trojan L, Müller-Wille R, Uhlig J.

Cardiovasc Intervent Radiol. 2018 Feb;41(2):277-283. doi: 10.1007/s00270-017-1816-9. Epub 2017 Oct 26.

PMID:
29075878
12.

Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design.

Ligibel JA, Barry WT, Alfano C, Hershman DL, Irwin M, Neuhouser M, Thomson CA, Delahanty L, Frank E, Spears P, Paskett ED, Hopkins J, Bernstein V, Stearns V, White J, Hahn O, Hudis C, Winer EP, Wadden TA, Goodwin PJ.

NPJ Breast Cancer. 2017 Sep 21;3:37. doi: 10.1038/s41523-017-0040-8. eCollection 2017. Review.

13.

Implementation of a Novel Medical School Multidisciplinary and Interprofessional Oncology Curriculum: a Mixed Method Study.

McKillip RP, Hahn OM, Bartkowiak B, Rosenberg CA, Olopade OI, Arora VM, Golden DW.

J Cancer Educ. 2019 Feb;34(1):50-55. doi: 10.1007/s13187-017-1264-x.

PMID:
28831669
14.

The Sense of Smell Impacts Metabolic Health and Obesity.

Riera CE, Tsaousidou E, Halloran J, Follett P, Hahn O, Pereira MMA, Ruud LE, Alber J, Tharp K, Anderson CM, Brönneke H, Hampel B, Filho CDM, Stahl A, Brüning JC, Dillin A.

Cell Metab. 2017 Jul 5;26(1):198-211.e5. doi: 10.1016/j.cmet.2017.06.015.

15.

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance).

Edelman MJ, Wang X, Hodgson L, Cheney RT, Baggstrom MQ, Thomas SP, Gajra A, Bertino E, Reckamp KL, Molina J, Schiller JH, Mitchell-Richards K, Friedman PN, Ritter J, Milne G, Hahn OM, Stinchcombe TE, Vokes EE; Alliance for Clinical Trials in Oncology.

J Clin Oncol. 2017 Jul 1;35(19):2184-2192. doi: 10.1200/JCO.2016.71.3743. Epub 2017 May 10.

16.

Men's Eating and Living (MEAL) study (CALGB 70807 [Alliance]): recruitment feasibility and baseline demographics of a randomized trial of diet in men on active surveillance for prostate cancer.

Parsons JK, Pierce JP, Mohler J, Paskett E, Jung SH, Morris MJ, Small E, Hahn O, Humphrey P, Taylor J, Marshall J.

BJU Int. 2018 Apr;121(4):534-539. doi: 10.1111/bju.13890. Epub 2017 May 21.

17.

Dietary restriction protects from age-associated DNA methylation and induces epigenetic reprogramming of lipid metabolism.

Hahn O, Grönke S, Stubbs TM, Ficz G, Hendrich O, Krueger F, Andrews S, Zhang Q, Wakelam MJ, Beyer A, Reik W, Partridge L.

Genome Biol. 2017 Mar 28;18(1):56. doi: 10.1186/s13059-017-1187-1.

18.

Animal Models for Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS): Achievements and Future Perspectives.

Budai A, Fulop A, Hahn O, Onody P, Kovacs T, Nemeth T, Dunay M, Szijarto A.

Eur Surg Res. 2017;58(3-4):140-157. doi: 10.1159/000453108. Epub 2017 Mar 9. Review.

PMID:
28273656
19.

Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial.

Choueiri TK, Halabi S, Sanford BL, Hahn O, Michaelson MD, Walsh MK, Feldman DR, Olencki T, Picus J, Small EJ, Dakhil S, George DJ, Morris MJ.

J Clin Oncol. 2017 Feb 20;35(6):591-597. doi: 10.1200/JCO.2016.70.7398. Epub 2016 Nov 14.

20.

Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study-CALGB 30607 (Alliance).

Baggstrom MQ, Socinski MA, Wang XF, Gu L, Stinchcombe TE, Edelman MJ, Baker S Jr, Feliciano J, Novotny P, Hahn O, Crawford JA, Vokes EE.

J Thorac Oncol. 2017 May;12(5):843-849. doi: 10.1016/j.jtho.2017.01.022. Epub 2017 Feb 1.

21.

Interdisciplinary Oncology Education: a National Survey of Trainees and Program Directors in the United States.

Akthar AS, Hellekson CD, Ganai S, Hahn OM, Maggiore RJ, Cohen EE, Posner MC, Chmura SJ, Howard AR, Golden DW.

J Cancer Educ. 2018 Jun;33(3):622-626. doi: 10.1007/s13187-016-1139-6.

PMID:
27873183
22.

No Exit: Identifying Avoidable Terminal Oncology Intensive Care Unit Hospitalizations.

Daly B, Hantel A, Wroblewski K, Balachandran JS, Chow S, DeBoer R, Fleming GF, Hahn OM, Kline J, Liu H, Patel BK, Verma A, Witt LJ, Fukui M, Kumar A, Howell MD, Polite BN.

J Oncol Pract. 2016 Oct;12(10):e901-e911.

23.

In depth evaluation of the prognostic and predictive utility of PTEN immunohistochemistry in colorectal carcinomas: performance of three antibodies with emphasis on intracellular and intratumoral heterogeneity.

Ágoston EI, Micsik T, Ács B, Fekete K, Hahn O, Baranyai Z, Dede K, Bodoky G, Bursics A, Kulka J, Krenács T, Győrffy B, Harsányi L, Szász AM.

Diagn Pathol. 2016 Jul 8;11(1):61. doi: 10.1186/s13000-016-0508-0.

24.

Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance).

Dickler MN, Barry WT, Cirrincione CT, Ellis MJ, Moynahan ME, Innocenti F, Hurria A, Rugo HS, Lake DE, Hahn O, Schneider BP, Tripathy D, Carey LA, Winer EP, Hudis CA.

J Clin Oncol. 2016 Aug 1;34(22):2602-9. doi: 10.1200/JCO.2015.66.1595. Epub 2016 May 2.

25.

Stereotactic body radiotherapy for oligometastatic breast cancer: a new standard of care, or a medical reversal in waiting?

Drazer MW, Salama JK, Hahn OM, Weichselbaum RR, Chmura SJ.

Expert Rev Anticancer Ther. 2016 Jun;16(6):625-32. doi: 10.1080/14737140.2016.1178577. Epub 2016 May 10. Review.

PMID:
27078719
26.

Fluoxetine treatment prevents the inflammatory response in a mouse model of posttraumatic stress disorder.

Kao CY, He Z, Zannas AS, Hahn O, Kühne C, Reichel JM, Binder EB, Wotjak CT, Khaitovich P, Turck CW.

J Psychiatr Res. 2016 May;76:74-83. doi: 10.1016/j.jpsychires.2016.02.003. Epub 2016 Feb 8.

PMID:
26897419
27.

[The importance of postoperative circulatory alterations in hepatic surgery].

Koós O, Kovács T, Fülöp A, Pekli D, Ónody P, Lukovich P, Harsányi L, Kupcsulik P, Hahn O, Szijártó A.

Orv Hetil. 2015 Nov 29;156(48):1938-48. doi: 10.1556/650.2015.30289. Review. Hungarian.

PMID:
26588852
28.

Induction of proliferation of basal epidermal keratinocytes by cold atmospheric-pressure plasma.

Hasse S, Duong Tran T, Hahn O, Kindler S, Metelmann HR, von Woedtke T, Masur K.

Clin Exp Dermatol. 2016 Mar;41(2):202-9. doi: 10.1111/ced.12735. Epub 2015 Jul 15.

PMID:
26175125
29.

Medical Student Knowledge of Oncology and Related Disciplines: a Targeted Needs Assessment.

Oskvarek J, Braunstein S, Farnan J, Ferguson MK, Hahn O, Henderson T, Hong S, Levine S, Rosenberg CA, Golden DW.

J Cancer Educ. 2016 Sep;31(3):529-32. doi: 10.1007/s13187-015-0876-2.

30.

Chest Compression Synchronized Ventilation versus Intermitted Positive Pressure Ventilation during Cardiopulmonary Resuscitation in a Pig Model.

Kill C, Galbas M, Neuhaus C, Hahn O, Wallot P, Kesper K, Wulf H, Dersch W.

PLoS One. 2015 May 26;10(5):e0127759. doi: 10.1371/journal.pone.0127759. eCollection 2015.

31.

[Laparoscopic surgery of benign liver tumours].

Kupcsulik P, Hahn O, Szíjártó A, Zsirka A, Winternitz T, Lukovich P, Fekete K.

Magy Seb. 2015 Feb;68(1):3-7. doi: 10.1556/MaSeb.68.2015.1.1. Hungarian.

PMID:
25704777
32.

Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance).

Sikov WM, Berry DA, Perou CM, Singh B, Cirrincione CT, Tolaney SM, Kuzma CS, Pluard TJ, Somlo G, Port ER, Golshan M, Bellon JR, Collyar D, Hahn OM, Carey LA, Hudis CA, Winer EP.

J Clin Oncol. 2015 Jan 1;33(1):13-21. doi: 10.1200/JCO.2014.57.0572. Epub 2014 Aug 4.

33.

Mechanical ventilation during cardiopulmonary resuscitation with intermittent positive-pressure ventilation, bilevel ventilation, or chest compression synchronized ventilation in a pig model.

Kill C, Hahn O, Dietz F, Neuhaus C, Schwarz S, Mahling R, Wallot P, Jerrentrup A, Steinfeldt T, Wulf H, Dersch W.

Crit Care Med. 2014 Feb;42(2):e89-95. doi: 10.1097/CCM.0b013e3182a63fa0.

PMID:
24158168
34.

Answer to the editorial letter from E. Harrison.

Hahn O, Kupcsulik P.

J Surg Oncol. 2013 Jul;108(1):76-7. doi: 10.1002/jso.23354. No abstract available.

PMID:
23788056
35.

[ALPPS (Associated Liver Partition and Portal vein ligation for Staged hepatectomy) -- faster and greater growth of liver].

Hahn O, Dudás I, Pajor P, Györke T, Korom C, Zsirka-Klein A, Kupcsulik P, Harsányi L.

Magy Seb. 2013 Feb;66(1):21-6. doi: 10.1556/MaSeb.66.2013.1.3. Hungarian.

PMID:
23428724
36.

A Novel Approach to Visualizing Dark Matter Simulations.

Kaehler R, Hahn O, Abel T.

IEEE Trans Vis Comput Graph. 2012 Dec;18(12):2078-87. doi: 10.1109/TVCG.2012.187.

PMID:
26357114
37.

Randomized controlled trials and comparative effectiveness research.

Hahn OM, Schilsky RL.

J Clin Oncol. 2012 Dec 1;30(34):4194-201. doi: 10.1200/JCO.2012.42.2352. Epub 2012 Oct 15. Review.

PMID:
23071239
38.

Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma.

Ranck MC, Golden DW, Corbin KS, Hasselle MD, Liauw SL, Stadler WM, Hahn OM, Weichselbaum RR, Salama JK.

Am J Clin Oncol. 2013 Dec;36(6):589-95. doi: 10.1097/COC.0b013e31825d52b2.

PMID:
22868242
39.

T cells that target carcinoembryonic antigen eradicate orthotopic pancreatic carcinomas without inducing autoimmune colitis in mice.

Chmielewski M, Hahn O, Rappl G, Nowak M, Schmidt-Wolf IH, Hombach AA, Abken H.

Gastroenterology. 2012 Oct;143(4):1095-107.e2. doi: 10.1053/j.gastro.2012.06.037. Epub 2012 Jun 27.

PMID:
22750462
40.

[Gallbladder surgery].

Harsányi L, Hahn O.

Magy Seb. 2012 Jun;65(3):150-3. doi: 10.1556/MaSeb.65.2012.3.9. Review. Hungarian. No abstract available.

PMID:
22717969
41.

Reconstruction procedure for 3D micro X-ray absorption fine structure.

Lühl L, Mantouvalou I, Malzer W, Schaumann I, Vogt C, Hahn O, Kanngiesser B.

Anal Chem. 2012 Feb 21;84(4):1907-14. doi: 10.1021/ac202285d. Epub 2012 Feb 3.

PMID:
22303902
42.

Phase II trial of temsirolimus in patients with metastatic breast cancer.

Fleming GF, Ma CX, Huo D, Sattar H, Tretiakova M, Lin L, Hahn OM, Olopade FO, Nanda R, Hoffman PC, Naughton MJ, Pluard T, Conzen SD, Ellis MJ.

Breast Cancer Res Treat. 2012 Nov;136(2):355-63. doi: 10.1007/s10549-011-1910-7. Epub 2012 Jan 13.

43.

Analytical techniques in art, archaeology and conservation science.

Hahn O.

Anal Bioanal Chem. 2012 Feb;402(4):1411. doi: 10.1007/s00216-011-5586-y. No abstract available.

PMID:
22159464
44.

The Egmont Master phenomenon: X-ray fluorescence spectrometric and paper studies for art history research.

Dietz G, Ketelsen T, Hoss M, Simon O, Wintermann C, Wolff T, Rabin I, Hahn O.

Anal Bioanal Chem. 2012 Feb;402(4):1505-15. doi: 10.1007/s00216-011-5309-4. Epub 2011 Sep 18.

PMID:
21928082
45.

A study of degradation of historic parchment using small-angle X-ray scattering, synchrotron-IR and multivariate data analysis.

Možir A, Gonzalez L, Kralj Cigić I, Wess TJ, Rabin I, Hahn O, Strlič M.

Anal Bioanal Chem. 2012 Feb;402(4):1559-66. doi: 10.1007/s00216-011-5392-6. Epub 2011 Sep 18.

PMID:
21928080
46.

XRF-analysis of fine and ultrafine particles emitted from laser printing devices.

Barthel M, Pedan V, Hahn O, Rothhardt M, Bresch H, Jann O, Seeger S.

Environ Sci Technol. 2011 Sep 15;45(18):7819-25. doi: 10.1021/es201590q. Epub 2011 Aug 25.

PMID:
21809840
47.

Provenance studies on Dead Sea scrolls parchment by means of quantitative micro-XRF.

Wolff T, Rabin I, Mantouvalou I, Kanngiesser B, Malzer W, Kindzorra E, Hahn O.

Anal Bioanal Chem. 2012 Feb;402(4):1493-503. doi: 10.1007/s00216-011-5270-2. Epub 2011 Jul 31.

PMID:
21805315
48.

The effect of ischemic preconditioning on redox status during liver resections--randomized controlled trial.

Hahn O, Blázovics A, Váli L, Kupcsulik PK.

J Surg Oncol. 2011 Nov 1;104(6):647-53. doi: 10.1002/jso.21907. Epub 2011 Jul 8.

PMID:
21744346
49.

3D micro-XRF for cultural heritage objects: new analysis strategies for the investigation of the Dead Sea Scrolls.

Mantouvalou I, Wolff T, Hahn O, Rabin I, Lühl L, Pagels M, Malzer W, Kanngiesser B.

Anal Chem. 2011 Aug 15;83(16):6308-15. doi: 10.1021/ac2011262. Epub 2011 Jul 20.

PMID:
21711051
50.

Single-port cholecystectomy through the lateral ring of the left inguinal hernia.

Lukovich P, Hahn O, Tarjányi M.

Surg Innov. 2011 Sep;18(3):NP1-3. doi: 10.1177/1553350610392930. Epub 2011 Mar 7.

PMID:
21385757

Supplemental Content

Support Center